Organotypic glioma spheroids for screening of experimental therapies: How many spheroids and sections are required?

Cytometry Part A

Volumn 75, Issue 6, 2009, Pages 528-534

  De Witt Hamer, Philip C ^a   Leenstra, Sieger ^a   Van Noorden, Cornelis J F ^a,b   Zwinderman, Aeilko H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Automated image analysis; Drug screening assays; Glioma; Lactate dehydrogenase activity; Organotypic spheroids; Power analysis; Sample size; Statistical methodology

Indexed keywords

ARTICLE; AUTOMATION; CONTROLLED STUDY; DRUG SCREENING; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMAGE ANALYSIS; PRIORITY JOURNAL; SAMPLE SIZE; TUMOR CELL CULTURE; TUMOR SPHEROID;

CELL CULTURE TECHNIQUES; CELL SURVIVAL; GLIOMA; HUMANS; L-LACTATE DEHYDROGENASE; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 66449096534     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20716     Document Type: Article

References (23)

1. Kunz-Schughart LA, Freyer JP, Hofstaedter F, Ebner R. The use of 3-D cultures for high-throughput screening: The multicellular spheroid model. J Biomol Screen 2004;9:273-285. (Pubitemid 40503539)
2. De Witt Hamer PC, Van Tilborg AAG, Eijk PP, Sminia P, Troost D, Van Noorden CJF, Ylstra B, Leenstra S. The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids. Oncogene 2008;27:2091-2096.
3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-996. (Pubitemid 40349501)
4. Hirschberg H, Sun CH, Tromberg BJ, Yeh AT, Madsen SJ. Enhanced cytotoxic effects of 5-aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids. J Neurooncol 2004;70:289-299. (Pubitemid 40057957)
5. Smith K, Gunaratnam L, Morley M, Franovic A, Mekhail K, Lee S. Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer. Cancer Res 2005;65:5221-5230. (Pubitemid 40827332)
6. Kaaijk P, Troost D, Sminia P, Hulshof MC, van der Kracht AH, Leenstra S, Bosch DA. Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastomas. Eur J Cancer 1997;33:645-651. (Pubitemid 27223752)
7. Bartholoma P, Impidjati, Reininger-Mack A, Zhang Z, Thielecke H, Robitzki A. A more aggressive breast cancer spheroid model coupled to an electronic capillary sensor system for a high-content screening of cytotoxic agents in cancer therapy: 3-Dimensional in vitro tumor spheroids as a screening model. J Biomol Screen 2005;10:705-714. (Pubitemid 41476805)
8. Gunther W, Pawlak E, Damasceno R, Arnold H, Terzis AJ. Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids. Br J Cancer 2003;88:463-469. (Pubitemid 36308160)
9. Golas JM, Lucas J, Etienne C, Golas J, Discafani C, Sridharan L, Boghaert E, Arndt K, Ye F, Boschelli DH, Li F, Titsch C, Huselton C, Chaudhary I, Boschelli F. SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models. Cancer Res 2005;65:5358-5364. (Pubitemid 40827349)
10. Terzis AJ, Thorsen F, Heese O, Visted T, Bjerkvig R, Dahl O, Arnold H, Gundersen G. Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. Br J Cancer 1997;75:1744-1752. (Pubitemid 27230698)
11. Bren-Mattison Y, Van P, V, Chan D, Winn R, Geraci MW, Nemenoff RA. Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC). Oncogene 2005;24:1412-1422.
12. Xing H, Wang S, Hu K, Tao W, Li J, Gao Q, Yang X, Weng D, Lu Y, Ma D. Effect of the cyclin-dependent kinases inhibitor p27 on resistance of ovarian cancer multicellular spheroids to anticancer chemotherapy. J Cancer Res Clin Oncol 2005;131:511-519. (Pubitemid 41215306)
13. De Witt Hamer PC, Jonker A, Leenstra S, Ruijter JM, Van Noorden CJ. Quantification of viability in organotypic multicellular spheroids of human malignant glioma using lactate dehydrogenase activity: A rapid and reliable automated assay. J Histochem Cytochem 2005;53:23-34. (Pubitemid 40130117)
14. Van Noorden CJF, Frederiks WM. Enzyme Histochemistry. A Laboratory Manual of Current Methods. Oxford: Bios Scientific Publishers; 1992.
15. Frederiks WM, Tukkie R, Grundeman PF, Hoebe C, Schellens JPM. Combined enzyme histochemical and ultrastructural study on cryostat sections of pig heart to detect early reperfusion damage after ischaemia. J Pathol 1995;175:339-348.
16. Chieco P, Jonker A, Van Noorden CJF. Image Cytometry. Oxford: Bios Scientific Publishers; 2001.
17. Howard CV, Reed MG. Unbiased Stereology. Oxford: Bios Scientific Publishers; 1998.
18. Mouton PR. Principles and Practices of Unbiased Stereology. Baltimore: Johns Hopkins University Press; 2002.
19. Sokal RR, Rohlf FJ. Biometry: the Principles and Practices of Statistics in Biological Research. New York: Freeman and Company; 2003.
20. Zwinderman AH, Voskuyl AE, Schelhaas DD, van Duinen SG, van der Bas JM, Hazes JM. Diagnostic strategies for the histological examination of muscle biopsy specimens for the assessment of vasculitis in rheumatoid arthritis. Stat Med 2000;19:3433-3447. (Pubitemid 32056695)
21. Cochran WG. Ratio estimators. In: Cochran WG, editor. Sampling Techniques. Hoboken: Wiley; 1997.
22. Ludbrook J. Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 1998;25:1032-1037. (Pubitemid 29011526)
23. Gundersen HJ, Osterby R. Optimizing sampling efficiency of stereological studies in biology: or 'do more less well' J Microsc 1981;121:65-73.